Merck asks FDA to authorize promising anti-COVID pill
NPR WASHINGTON — Drugmaker Merck asked U.S. regulators Monday to authorize its pill against COVID-19 in what would add an
Read More
Columbus Day Observed Today
AMAC Foundation employees are off this day and thus Medicare Report will return tomorrow with our regular content.
Read MoreDrug Price Negotiation Doesn’t Mean the Government Will Restrict Access to Medicines
(By Juliette Cubanski and Larry Levitt for Kaiser Family Foundation published Oct 07, 2021) As the Congressional debate over budget reconciliation
Read MoreDC mayor pays off past-due premiums for residents, small businesses
(By Nick Moran for Becker’s Hospital Review) Washington, D.C., Mayor Muriel Bowser paid $13.5 million in overdue health premiums for
Read MoreCovid Immunity Through Infection or Vaccination: Are They Equal?
(By Arthur Allen for Kaiser Health News) Dr. Aaron Kheriaty, a University of California-Irvine psychiatry professor, felt he didn’t need
Read MoreNew brain maps could help the search for Alzheimer’s treatments
(By Jon Hamilton for NPR) An international consortium involving hundreds of scientists has unveiled highly detailed maps of the brain area
Read MoreEmployer health benefit costs expected to jump about 5%, reports say: 29 numbers to know
(By Nick Moran for Becker’s Hospital Review) Two studies published Oct. 6 — one by Mercer shared with Becker’s and one
Read MoreMedtronic releases urgent recall for insulin pump vulnerable to hackers: 3 details
(By Hannah Mitchell for Becker’s Hospital Review) Medtronic has issued an urgent recall for the remote control of certain insulin pumps
Read MoreOlder Americans bore the brunt of antibiotic-resistant infections, study finds
(By Ed Silverman for STAT) Older Americans were disproportionately affected by several different types of infection for which antibiotics were
Read More3 states to launch new ACA marketplaces
(By Nick Moran for Becker’s Hospital Review) Kentucky, Maine and New Mexico are all launching new state marketplaces for 2022, transitioning
Read More